KRONOS BIO

Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. It develops therapies that modulate historically undruggable targets. The company leverages deep capabilities in high-throughput small-molecule microarrays (SMM), targeted protein degradation, and cancer biology in order to identify potent and selective compounds against transcription factors and other central drivers of oncogenic signaling.

KRONOS BIO

Social Links:

Twitter

Industry:

Biotechnology Chemical Therapeutics

Founded:

2017-01-01

Address:

San Mateo, California, United States

Country:

United States

Website Url:

http://www.kronosbio.com

Total Employee:

11+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

278 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins

Similar Organizations

1859-logo

1859

1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

sunshine-biopharma-logo

Sunshine Biopharma

Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.

Current Advisors List

jakob-loven_image

Jakob Loven Board of Directors @ Kronos Bio
Board_member

marianne-de-backer_image

Marianne De Backer Member Board of Directors @ Kronos Bio
Board_member
2021-01-01

Current Employees Featured

angela-koehler_image

Angela Koehler
Angela Koehler Scientific Founder @ Kronos Bio
Scientific Founder
2017-11-01

christopher-wilfong_image

Christopher Wilfong
Christopher Wilfong Chief Operating Officer and Co-Founder @ Kronos Bio
Chief Operating Officer and Co-Founder
2017-11-01

norbert-bischofberger_image

Norbert Bischofberger
Norbert Bischofberger President & Chief Executive Officer @ Kronos Bio
President & Chief Executive Officer
2018-08-01

jorge-dimartino_image

Jorge DiMartino
Jorge DiMartino Chief Medical Officer & Executive Vice President, Clinical Development @ Kronos Bio
Chief Medical Officer & Executive Vice President, Clinical Development
2019-12-01

douglas-c-saffran_image

Douglas C. Saffran
Douglas C. Saffran Vice President, Pharmacology @ Kronos Bio
Vice President, Pharmacology
2018-08-01

zung-to_image

Zung To
Zung To Hematology Franchise Leader, VP Development Operations, Portfolio Management, Biometrics & Quality @ Kronos Bio
Hematology Franchise Leader, VP Development Operations, Portfolio Management, Biometrics & Quality
2020-05-01

wes-trotter_image

Wes Trotter
Wes Trotter Vice President, Chemistry @ Kronos Bio
Vice President, Chemistry
2020-01-01

charles-lin_image

Charles Lin
Charles Lin Vice President, Biology @ Kronos Bio
Vice President, Biology
2019-12-01

christopher-lee_image

Christopher Lee
Christopher Lee Vice President, Program Management @ Kronos Bio
Vice President, Program Management

yasir-b-al-wakeel_image

Yasir B. Al-Wakeel
Yasir B. Al-Wakeel CFO & Head of Corporate Development @ Kronos Bio
CFO & Head of Corporate Development
2020-01-01

Founder

angela-koehler_image

Angela Koehler

christopher-wilfong_image

Christopher Wilfong

joshua-kazam_image

Joshua Kazam

Stock Details

Company's stock symbol is NASDAQ:KRON

Investors List

fidelity-management-and-research-company_image

Key Employee Changes

Date	New article
2022-02-01	Kronos Bio Announces Appointment of Elizabeth Olek as Senior Vice President of Clinical Development
2021-09-14	Kronos Bio Appoints Marni Kottle as Senior Vice President of Corporate Communications and Investor Relations
2020-08-19	Kronos Bio Names Yasir Al-Wakeel as Its First Chief Financial Officer
2020-07-20	Kronos Bio Appoints Barbara Kosacz, Chief Operating Officer and General Counsel
2020-06-16	Kronos Bio Appoints Christopher Dinsmore Chief Scientific Officer

Official Site Inspections

http://www.kronosbio.com Semrush global rank: 4.57 M Semrush visits lastest month: 2.27 K

Host Informations
Whois Informations

Loading ...